Osilodrostat Recruiting Phase 2 Trials for Cushing's Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03606408Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699